Skip to main content
. 2012 Apr 9;209(4):641–651. doi: 10.1084/jem.20112071

Figure 4.

Figure 4.

CD4+ TN deficiency does not accelerate disease progression. (A) Kaplan-Meier plot of the time to end-stage AIDS (day of disease mandated necropsy) for CD4+ TN-depleted (red, n = 9) versus -repleted RMs (blue, n = 9) over the 1 yr of follow-up. Log rank analysis indicated that rate of progression to AIDS between the two groups was not significantly different (P = 0.72). (B) Major pathological findings at necropsy of study RMs progressing to end-stage AIDS (n = 5 and 4 for CD4+ TN-depleted vs. -repleted RMs, respectively). (C) Flow cytometric profiles (as described in Fig. 1 M) of CD4+ T cell populations in blood and various LNs at necropsy of representative CD4+ TN-depleted (#24273, progression to AIDS at day 190 pi) and CD4+ TN-repleted (#25522, progression to AIDS at day 163 pi) RMs. The percentage of TN of gated events (total CD4+ T) is shown in red in the bottom left. The percentage of CD4+ of total T cells is shown in black at the top right. (D) Comparison of CD4+/CD8+ ratios within the TM populations in blood and selected secondary lymphoid tissues (axillary and inguinal LNs and spleen) and effector sites (liver, BAL, and small intestinal mucosa) of four of five CD4+ TN-depleted (red) and four of four CD4+ TN-repleted (blue) RMs studied at necropsy (one CD4+ TN-depleted RM could not be analyzed as a result of inadequate staining of cell preparations obtained at necropsy). Shown are box plots, with boxes and whiskers indicating interquartile ranges (25th–75th percentiles) and 10th–90th percentile values, respectively. Statistical analysis of differences in this parameter between groups was analyzed as described in the Materials and methods (NS, nonsignificant).